CEO of Ozempic prescription startup Calibrate steps down as investors eye ‘rapid downsizing’ of consumer businessExclusive: CEO of Ozempic prescription startup Calibrate steps down as investors eye ‘rapid down-sizing’ of consumer business - Fortune
fortune.comSubmitted by fortune4233 in business
Calibrate CEO Isabelle Kenyon is stepping down as chief executive and will no longer oversee day-to-day operations.